1. Yang Q, Lin W, Liu Z, Zhu J, Huang N, Cui Z, et al. RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma. Cell Death Dis. 2018; 9:146.
Article
2. Zhang M, Zhang L, Cui M, Ye W, Zhang P, Zhou S, et al. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer. Oncotarget. 2017; 8:49053–49063.
Article
3. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet. 2010; 42:759–763.
4. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 2010; 42:764–767.
Article
5. Wang ZJ, Wang DX, Wang ZG, Pathology DO, Hospital ZP, Pediatrics DO. Expression of PLCE1 and p53 in colorectal cancer and its significance. J Clin Exp Med. 2018; 3:247–251.
6. Cheng H, Luo C, Wu X, Zhang Y, He Y, Wu Q, et al. shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo. Urology. 2011; 78:474.e7–474.e11.
7. Chen H, Zhao J, Ji F. The progress of correlation research about PLCE1 gene and gastric cancer occurrence. J Modern Oncol. 2016; 24:2160–2162.
8. Jomrich G, Paireder M, Gleiss A, Kristo I, Harpain L, Schoppmann SF. Comparison of inflammation-based prognostic scores in a cohort of patients with resectable esophageal cancer. Gastroenterol Res Pract. 2017; 2017:1678584.
Article
9. Lu Z, Long Y, Cun X, Wang X, Li J, Mei L, et al. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale. 2018; 10:9957–9970.
Article
10. Long L, Pang XX, Lei F, Zhang JS, Wang W, Liao LD, et al. SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer. Cell Mol Life Sci. 2018; 75:2643–2661.
Article
11. Zhao HW, Cui YF, Jiang JZ, Che N, Jing YE, Wang CY, et al. [Sesamin suppresses mast cell activation through inhibition of PKCα/NF-κB signaling pathway]. Zhongguo Mian Yi Xue Za Zhi. 2018; 2:167–171.
12. Racchi M, Buoso E, Ronfani M, Serafini MM, Galasso M, Lanni C, et al. Role of hormones in the regulation of RACK1 expression as a signaling checkpoint in immunosenescence. Int J Mol Sci. 2017; 18:1453.
Article
13. Song T, Zheng YM, Vincent PA, Cai D, Rosenberg P, Wang YX. Canonical transient receptor potential 3 channels activate NF-κB to mediate allergic airway disease via PKC-α/IκB-α and calcineurin/IκB-β pathways. FASEB J. 2016; 30:214–229.
Article
14. Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012; 39:9105–9111.
Article
15. Guo LY, Yang N, Hu D, Zhao X, Feng B, Zhang Y, et al. PLCE1 rs2274223 polymorphism and susceptibility to esophageal cancer: a meta-analysis. Asian Pac J Cancer Prev. 2014; 15:9107–9112.
Article
16. Cui XB, Li S, Li TT, Peng H, Jin TT, Zhang SM, et al. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma. Oncotarget. 2016; 7:1777–1795.
Article
17. Li Y, An J, Huang S, Liao H, Weng Y, Cai S, et al. PLCE1 suppresses p53 expression in esophageal cancer cells. Cancer Invest. 2014; 32:236–240.
Article
18. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 promotes esophageal cancer cell progression by maintaining the transcriptional activity of snail. Neoplasia. 2017; 19:154–164.
Article
19. Zhao L, Wei ZB, Yang CQ, Chen JJ, Li D, Ji AF, et al. Effects of PLCE1 gene silencing by RNA interference on cell cycling and apoptosis in esophageal carcinoma cells. Asian Pac J Cancer Prev. 2014; 15:5437–5442.
Article
20. Zhang B, Liu T, Zhou H. [The promoting research of phospholipase C epsilon-1 on nasal Th2 cell polarization]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014; 28:1363–1366.
21. Li J, Li Y, Wang B, Ma Y, Chen P. Id-1 promotes migration and invasion of non-small cell lung cancer cells through activating NF-κB signaling pathway. J Biomed Sci. 2017; 24:95.
Article
22. Che R, Zhang A. Mechanisms of glucocorticoid resistance in idiopathic nephrotic syndrome. Kidney Blood Press Res. 2013; 37:360–378.
Article
23. Ordoñez-Moreno A, Rodriguez-Monterrosas C, Cortes-Reynosa P, Perez-Carreon JI, Perez Salazar E. Erythropoietin induces an epithelial to mesenchymal transition-like process in mammary epithelial cells MCF10A. J Cell Biochem. 2017; 118:2983–2992.
Article
24. Mao M, Cai L, Hu J, Hu L. Investigating the migration and invasion of human squamous cervical carcinoma line Siha stimulated by TGF-β1 and its underlying mechanisms. Chin J Cell Biol. 2015; 1:59–65.
25. Cui XB, Pang XL, Li S, Jin J, Hu JM, Yang L, et al. Elevated expression patterns and tight correlation of the PLCE1 and NF-κB signaling in Kazakh patients with esophageal carcinoma. Med Oncol. 2014; 31:791.
Article
26. Hsieh YH, Wu TT, Tsai JH, Huang CY, Hsieh YS, Liu JY. PKCalpha expression regulated by Elk-1 and MZF-1 in human HCC cells. Biochem Biophys Res Commun. 2006; 339:217–225.
27. Lahn M, Paterson BM, Sundell K, Ma D. The role of protein kinase C-alpha (PKC-alpha) in malignancies of the gastrointestinal tract. Eur J Cancer. 2004; 40:10–20.
Article
28. van der Vorst EPC, Theodorou K, Wu Y, Hoeksema MA, Goossens P, Bursill CA, et al. High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-κB/STAT1-IRF1 signaling. Cell Metab. 2017; 25:197–207.